Effective Single Twymeeg Administration for Elderly Patient with Type 2 Diabetes (T2D), Arthralgia and Depression as Common Medical Problems

Background: Imeglimin (Twymeeg) has been effective for patients with type 2 diabetes (T2D). Case Presentation: The patient is an 82-year-old female with T2D, arthralgia, and depression. Results: She was given duloxetine hydrochloride (Cymbalta) and Twymeeg, leading to improved symptoms of low back pain (LBP), knee osteoarthritis, osteoporosis, depression, and possible mild cognitive impairment (MCI). HbA1c decreased from 8.8% to 7.1% for 4 months with a single administration of Twymeeg 2000mg/day. Discussion: In recent clinical practice, elderly cases often tend to have simultaneously these problems, which are medical and social crucial problems. Twymeeg and Cymbalta may be indispensable agents for future practice

Clinical Efficacy of Imeglimin (Twymeeg) for Elderly Patient with Type 2 Diabetes Mellitus (T2DM)

Background: As an oral hypoglycaemic agent (OHA), imeglimin (Twymeeg) has been recently introduced to clinical practice for patients with type 2 diabetes mellitus (T2DM) as Twymeeg. It has beneficial pharmacological mechanisms, which are improving insulin secretion, increasing insulin sensitivity, and decreasing insulin resistance. Case Presentation: The case is 84-year-old man with mild cognitive impairment (MCI) for 3 years. He visited late August, 2021 our clinic for general malaise and was pointed out to have post-prandial blood glucose 336 mg/dL and HbA1c 8.6%. He was diagnosed with T2DM. Results: He was started to be given imeglimin 1000mg twice a day, and then HbA1c value was decreased to 7.3% in 4 weeks and 5.7% in 8 weeks. During 9-12 weeks, he felt loss of appetite and reduced food intake. Biochemical examination on 12 weeks showed decreased values of TP, Alb, HbA1c, glucose, free T3, and normal values of TSH, free T4. Doses of imeglimin were 500 mg twice a day for 9-12 weeks and discontinued after 12 weeks. Discussion: Regarding appetite loss, possible causes may include MCI, previous history of gallbladder dyskinesia, adverse effect of imeglimin, and so on. Further development of research will be expected for imeglimin in the future

Field-orientation dependence of quantum phase transitions in the S=1/2 triangular-lattice antiferromagnet Ba3_3CoSb2_2O9_9

Ba$_3$CoSb$_2$O$_9$ approximates the two-dimensional spin-1/2 triangular-lattice Heisenberg antiferromagnet. This compound displays magnetic-field-induced quantum phase transitions, including the 1/3-magnetization-plateau, but its magnetization processes for the magnetic field $H$ parallel and perpendicular to the $c$ axis are different due to the weak easy-plane anisotropy and the weak interlayer antiferromagnetic exchange interaction. To elucidate how the quantum phase transitions change between these two field directions, we measured the field-angle dependence of the magnetization process in Ba$_3$CoSb$_2$O$_9$ using pulsed high magnetic fields. We compared obtained magnetic field-field angle phase diagram with those obtained by the large-size cluster mean-field method combined with a scaling scheme and the semiclassical theory. We also found a narrow 1/3-magnetization plateau and a high-field transition with a small magnetization jump for $H\,{\parallel}\,c$, not observed in the previous studies.Comment: 8 pages, 7 figures, to appear in Phys. Rev.

Gamergate controls dopamine levels of workers in <i>Diacamma</i> sp.

Introdução: O climatério representa uma fase de mudança e de transição no ciclo de vida feminino, durante o qual as mulheres experimentam alterações físicas e psicológicas decorrentes do hipoestrogenismo e envelhecimento. O Médico de Família é habitualmente o primeiro profissional de saúde a quem a mulher recorre para esclarecer as suas dúvidas e solicitar o alívio da sintomatologia climatérica, ocupando uma posição privilegiada para promover a capacitação e empowerment das utentes. Métodos: Promoveu-se um estudo observacional transversal, aplicando um questionário de auto-preenchimento a 92 mulheres, com idades compreendidas entre os 40 e os 60 anos, que frequentam os Centros de Saúde Norton de Matos e S. Martinho do Bispo (USF Mondego), de forma a avaliar a abordagem da menopausa nos Cuidados de Saúde Primários. A recolha dos dados decorreu de abril a julho de 2014. O tratamento estatístico foi efetuado através da plataforma estatística IBM SPSS v21.0. Resultados: Mais de metade das mulheres (55,4%) referiu ter conversado com o Médico de Família sobre a menopausa e todos os assuntos relacionados, todavia 19,6% ainda manifestavam dúvidas. O médico foi considerado a principal fonte de informação para 50% das inquiridas. A maioria das mulheres (77,2%) descreveu a presença de sintomas climatéricos, sendo os mais frequentes as dores ósseas (73,2%) e a ansiedade (67,6%). 39,1% das inquiridas indicaram a interferência do climatério na sua vida diária, sendo a vida familiar (69,4%) e a sexual (58,3%) as mais afetadas. Verificou-se uma associação significativa entre a presença de sintomas e a interferência do climatério na vida diária e na qualidade de vida da mulher. As mulheres sintomáticas (OR=12,983 com IC95% [2,808;60,033]) e as que referiram a interferência do climatério no dia a dia (OR=5,965 com IC95% [2,364;15,048]) apresentaram uma probabilidade aumentada de recorrer a consultas de Medicina Geral e Familiar. As infeções urinárias de repetição (91,7%) foram as queixas que mais motivaram a ida ao Médico de Família. Das mulheres sintomáticas, 45,1% referiram ter cuidados adicionais ou fazer algum tratamento. A terapêutica hormonal revelou-se a mais eficaz no alívio das queixas, tendo como prescritor mais frequente o Ginecologista (58,3%). Conclusão: O Médico de Família assume um papel crucial na capacitação e acompanhamento da mulher climatérica. Constatou-se que ainda permanecem dúvidas que necessitam de ser esclarecidas e que são necessárias normas que uniformizem a abordagem da menopausa na prática clínica.Introduction: The climacteric represents a time of change and transition in the female life cycle, during which women experience physical and psychological changes resulting from hypoestrogenism and aging. The general practitioner is usually the first health professional to whom a woman appeals to clarify her doubts and request relief from climacteric symptoms, occupying a privileged position to promote capacity building and empowerment of patients. Methods: It was promoted a cross-sectional observational study, applying a self-completion questionnaire to 92 women, aged between 40 and 60 years, who attend the health centers of Norton de Matos and S. Martinho do Bispo (USF Mondego), in order to evaluate the approach of menopause in Primary Health Care. Data collection took place from April to July 2014. The statistical analysis was performed by the statistical platform IBM SPSS v21.0. Results: More than half of women (55.4%) said they had talked to the general practitioner about menopause and all the related subjects, however 19.6% still had doubts. The doctor was considered the main source of information for 50% of the surveyed women. Most women (77.2%) described the presence of menopausal symptoms, the most common being bone pain (73.2%) and anxiety (67.6%). 39.1% of the surveyed indicated the interference of the climacteric in their everyday life, being the family life (69.4%) and the sexual life (58.3%) the most affected. There was a significant association between the presence of symptoms of menopause and the interference of the climacteric in daily life and quality of life. Symptomatic women (OR = 12.983 with 95% CI [2.808, 60.033]) and those who mentioned the interference of the climacteric in daily life (OR = 5.965 95% CI [2.364, 15.048]) had an increased likelihood of appealing to a general practitioner. Recurrent urinary tract infections (91.7%) were complaints that most commonly lead going to the general practitioner. Of symptomatic women, 45.1% said having additional care or getting some treatment. Hormone therapy proved more effective in relieving complaints, having the gynecologist as the most frequent prescriber (58.3%). Conclusion: The general practitioner plays a key role in the capacity building and monitoring of the climacteric woman. It was found that there are still questions that need to be clarified and that standards are necessary to standardize the approach of menopause in clinical practice

Required Elements in tRNA for Methylation by the Eukaryotic tRNA (Guanine-N2-) Methyltransferase (Trm11-Trm112 Complex)

The Saccharomyces cerevisiae Trm11 and Trm112 complex (Trm11-Trm112) methylates the 2-amino group of guanosine at position 10 in tRNA and forms N2-methylguanosine. To determine the elements required in tRNA for methylation by Trm11-Trm112, we prepared 60 tRNA transcript variants and tested them for methylation by Trm11-Trm112. The results show that the precursor tRNA is not a substrate for Trm11-Trm112. Furthermore, the CCA terminus is essential for methylation by Trm11-Trm112, and Trm11-Trm112 also only methylates tRNAs with a regular-size variable region. In addition, the G10-C25 base pair is required for methylation by Trm11-Trm112. The data also demonstrated that Trm11-Trm112 recognizes the anticodon-loop and that U38 in tRNAAla acts negatively in terms of methylation. Likewise, the U32-A38 base pair in tRNACys negatively affects methylation. The only exception in our in vitro study was tRNAValAAC1. Our experiments showed that the tRNAValAAC1 transcript was slowly methylated by Trm11-Trm112. However, position 10 in this tRNA was reported to be unmodified G. We purified tRNAValAAC1 from wild-type and trm11 gene deletion strains and confirmed that a portion of tRNAValAAC1 is methylated by Trm11-Trm112 in S. cerevisiae. Thus, our study explains the m2G10 modification pattern of all S. cerevisiae class I tRNAs and elucidates the Trm11-Trm112 binding sites

Evolution of two-step structural phase transition in Fe1+dTe detected by low-temperature x-ray diffraction

The low-temperature crystal structure of Fe1.13Te, which exhibits an anomalous two-step magnetic transition, was clarified by the systematic x-ray diffraction measurements. It was found that two-step structural phase transition, tetragonal-orthorhombic-monoclinic, occurred correspondingly to the two-step magnetic transition. The detailed analysis of the profile at 5 K indicated the coexistence of the minor orthorhombic area inside the major monoclinic lattice, which could explain the lower-shift (suppression) of the antiferromagnetic transition temperature in Fe1.13Te and suggest a possibility of superconductivity at the domain boundary.Comment: 12 pages, 3 figure

Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration.

The gut incretin glucagon-like peptide-1 (GLP-1) and the intestinotropic hormone GLP-2 are released from enteroendocrine L cells in response to ingested nutrients. Treatment with an exogenous GLP-2 analogue increases intestinal villous mass and prevents intestinal injury. Since GLP-2 is rapidly degraded by dipeptidyl peptidase 4 (DPP4), DPP4 inhibition may be an effective treatment for intestinal ulcers. We measured mRNA expression and DPP enzymatic activity in intestinal segments. Mucosal DPP activity and GLP concentrations were measured after administration of the DPP4 inhibitor sitagliptin (STG). Small intestinal ulcers were induced by indomethacin (IM) injection. STG was given before IM treatment, or orally administered after IM treatment with or without an elemental diet (ED). DPP4 mRNA expression and enzymatic activity were high in the jejunum and ileum. STG dose-dependently suppressed ileal mucosal enzyme activity. Treatment with STG prior to IM reduced small intestinal ulcer scores. Combined treatment with STG and ED accelerated intestinal ulcer healing, accompanied by increased mucosal GLP-2 concentrations. The reduction of ulcers by ED and STG was reversed by co-administration of the GLP-2 receptor antagonist. DPP4 inhibition combined with luminal nutrients, which up-regulate mucosal concentrations of GLP-2, may be an effective therapy for the treatment of small intestinal ulcers

Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology

Abe, S., Kobayashi, K., Oji, A. et al. Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology. Sci Rep 7, 15189 (2017). https://doi.org/10.1038/s41598-017-15033-